Improving the efficiency of CRISPR-Cas12a-based genome editing with site-specific covalent Cas12a-crRNA conjugates - PubMed (original) (raw)
. 2021 Nov 18;81(22):4747-4756.e7.
doi: 10.1016/j.molcel.2021.09.021. Epub 2021 Oct 13.
Affiliations
- PMID: 34648747
- DOI: 10.1016/j.molcel.2021.09.021
Free article
Improving the efficiency of CRISPR-Cas12a-based genome editing with site-specific covalent Cas12a-crRNA conjugates
Xinyu Ling et al. Mol Cell. 2021.
Free article
Abstract
The CRISPR-Cas12a system shows unique features compared with widely used Cas9, making it an attractive and potentially more precise alternative. However, the adoption of this system has been hindered by its relatively low editing efficiency. Guided by physical chemical principles, we covalently conjugated 5' terminal modified CRISPR RNA (crRNA) to a site-specifically modified Cas12a through biorthogonal chemical reaction. The genome editing efficiency of the resulting conjugated Cas12a complex (cCas12a) was substantially higher than that of the wild-type complex. We also demonstrated that cCas12a could be used for precise gene knockin and multiplex gene editing in a chimeric antigen receptor T cell preparation with efficiency much higher than that of the wild-type system. Overall, our findings indicate that covalently linking Cas nuclease and crRNA is an effective approach to improve the Cas12a-based genome editing system and could potentially provide an insight into engineering other Cas family members with low efficiency as well.
Keywords: Bio-orthogonal chemistry; CAR-T; CRISPR-Cas12a; Genetic Code Expansion.
Copyright © 2021 Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of interests The authors declare no competing interests.
Similar articles
- Multiplexed conditional genome editing with Cas12a in Drosophila.
Port F, Starostecka M, Boutros M. Port F, et al. Proc Natl Acad Sci U S A. 2020 Sep 15;117(37):22890-22899. doi: 10.1073/pnas.2004655117. Epub 2020 Aug 25. Proc Natl Acad Sci U S A. 2020. PMID: 32843348 Free PMC article. - Harnessing noncanonical crRNA for highly efficient genome editing.
Xun G, Zhu Z, Singh N, Lu J, Jain PK, Zhao H. Xun G, et al. Nat Commun. 2024 May 7;15(1):3823. doi: 10.1038/s41467-024-48012-x. Nat Commun. 2024. PMID: 38714643 Free PMC article. - Design and Evaluation of Guide RNA Transcripts with a 3'-Terminal HDV Ribozyme to Enhance CRISPR-Based Gene Inactivation.
Berkhout B, Gao Z, Herrera-Carrillo E. Berkhout B, et al. Methods Mol Biol. 2021;2167:205-224. doi: 10.1007/978-1-0716-0716-9_12. Methods Mol Biol. 2021. PMID: 32712922 Free PMC article. - CRISPR-Cas12a System for Biosensing and Gene Regulation.
Shi Y, Fu X, Yin Y, Peng F, Yin X, Ke G, Zhang X. Shi Y, et al. Chem Asian J. 2021 Apr 19;16(8):857-867. doi: 10.1002/asia.202100043. Epub 2021 Mar 18. Chem Asian J. 2021. PMID: 33638271 Review. - Application of CHyMErA Cas9-Cas12a combinatorial genome-editing platform for genetic interaction mapping and gene fragment deletion screening.
Aregger M, Xing K, Gonatopoulos-Pournatzis T. Aregger M, et al. Nat Protoc. 2021 Oct;16(10):4722-4765. doi: 10.1038/s41596-021-00595-1. Epub 2021 Sep 10. Nat Protoc. 2021. PMID: 34508260 Review.
Cited by
- Leveraging CRISPR gene editing technology to optimize the efficacy, safety and accessibility of CAR T-cell therapy.
Lei T, Wang Y, Zhang Y, Yang Y, Cao J, Huang J, Chen J, Chen H, Zhang J, Wang L, Xu X, Gale RP, Wang L. Lei T, et al. Leukemia. 2024 Oct 25. doi: 10.1038/s41375-024-02444-y. Online ahead of print. Leukemia. 2024. PMID: 39455854 Review. - Strategies for improving the genome-editing efficiency of class 2 CRISPR/Cas system.
Wang L, Han H. Wang L, et al. Heliyon. 2024 Sep 27;10(19):e38588. doi: 10.1016/j.heliyon.2024.e38588. eCollection 2024 Oct 15. Heliyon. 2024. PMID: 39397905 Free PMC article. Review. - Cracking the Code: Reprogramming the Genetic Script in Prokaryotes and Eukaryotes to Harness the Power of Noncanonical Amino Acids.
Jann C, Giofré S, Bhattacharjee R, Lemke EA. Jann C, et al. Chem Rev. 2024 Sep 25;124(18):10281-10362. doi: 10.1021/acs.chemrev.3c00878. Epub 2024 Aug 9. Chem Rev. 2024. PMID: 39120726 Review. - Gene editing therapy for cardiovascular diseases.
Wu X, Yang J, Zhang J, Song Y. Wu X, et al. MedComm (2020). 2024 Jul 5;5(7):e639. doi: 10.1002/mco2.639. eCollection 2024 Jul. MedComm (2020). 2024. PMID: 38974714 Free PMC article. Review. - Biosynthesis of Halogenated Tryptophans for Protein Engineering Using Genetic Code Expansion.
Guo Y, Cheng L, Hu Y, Zhang M, Liu R, Wang Y, Jiang S, Xiao H. Guo Y, et al. Chembiochem. 2024 Oct 16;25(20):e202400366. doi: 10.1002/cbic.202400366. Epub 2024 Sep 3. Chembiochem. 2024. PMID: 38958600 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources